Congressmen Optimistic About Bills Decoupling US From China on Drugs but Warn of Long Road Ahead

MIDVALE, UT - SEPTEMBER 10: A pharmacy technician grabs a bottle of drugs off a shelve at the central pharmacy of Intermountain Heathcare on September 10, 2018 in Midvale, Utah. IHC along with other hospitals and philanthropies are launching a nonprofit generic drug company called "Civica Rx" to help reduce cost and shortages of generic drugs. Photo by George Frey/Getty Images

A proposal to bring U.S. supply chains for critical products such as antibiotics and other medicines back from China stands an excellent chance of being approved in Congress, according to Rep. Michael Waltz (R-Fla.), one of the measure’s main proponents.

“I am confident it will pass. I think having both houses of Congress on board, the president is on board, the legislative vehicle and the national mood, I feel confident,” Waltz told The Epoch Times.